Healthcare-Associated Infection (HAI) Advisory Committee

Prevention Strategies Subcommittee

HAI Prevention Strategies Subcommittee logo

The Prevention Strategies Subcommittee evaluates current healthcare associated infection prevention strategies utilized by Arizona facilities. The subcommittee is also responsible for creating a toolkit for healthcare providers (including hospitals, long-term care facilities and assisted living facilities, dialysis centers, and ambulatory surgery centers) that will synthesize healthcare associated infection prevention, evidence, guidelines & best practices.

Objectives of the Prevention Strategies subcommittee:

  1. Evaluate current HAI prevention strategies utilized by Arizona facilities.
  2. Create a toolkit that catalogs existing HAI prevention evidence on the basis of strength of evidence, cost of intervention, ease of implementation, and sustainability.
  3. Supply ready to use information and educational resources to providers of care who may have restricted resources available.

Clostridium difficile Toolkit

Clostridium difficile
Clostridium difficile

Clostridium difficile is one of the most frequent causes of healthcare associated diarrhea. The spore-forming bacteria produce toxins that cause gastrointestinal illness in individuals and pose a threat to hospital patients and nursing home residents.

Prolonged antibiotic use is viewed as the primary risk factor for developing, Clostridium difficile infections (CDI). Therefore, widespread prevention efforts are necessary to reduce the spread of C.difficile in various healthcare settings.

The Prevention Strategies Subcommittee decided to focus its prevention efforts on CDI due to the increased incidence and severity of the organism. The subcommittee has created a CDI Prevention ToolkitPDF focusing on the areas of hand hygiene and contact precautions, surveillance for C.difficile, antibiotic treatment, environmental cleaning and education. The toolkit is designed to serve as a resource of tools to aid in issues associated with the surveillance, prevention and treatment of C.difficile infections.

Please recognize that each component of the toolkit will be field tested in the appropriate setting. Feedback from the testing will help make improvements to the toolkit. After field testing the components of the toolkit, please complete the toolkit evaluation.